Spermosens are active in medical technology. The company specializes in the development of medical devices. The product portfolio is broad and includes products for male infertility and individually tailored fertility treatments. Research and development is conducted via its own technological platform that analyzes sperm quality, which is further used for medical data and potential fertilization. The largest operations are in the Nordic market.

Quotes for Spermosens AB (publ)

Right Now

+/-
0.004
%
2,58%
Latest
0.159
High
0.19
Low
0.1415
Volume
389 148
Turnover (SEK)
60 699
Market Value (MSEK)
6,5
Time (Latest trade)
2024-04-18 16:56

Board

CEO

  • Ulrik Nilsson (tf)

Chairperson of the Board

  • Eva Nilsagård

Board

  • Christina Östberg Lloyd
  • Ingela Liljeqvist Soltic
  • Kushagr Punyani
  • Sören Melsing Frederiksen

Videos

Largest Owners

Name Capital % Votes % Date
Avanza Pension 14,71 14,71 2024-03-26
Kushagr Punyani 3,98 3,98 2024-03-26
Nordnet Pensionsförsäkring 2,81 2,81 2024-03-26
Max Söllingvraa 1,79 1,79 2024-03-26
Mohamad Takwa 1,70 1,70 2024-03-26
Henrik Ruö Jensen 1,52 1,52 2024-03-26
Jony Demir 1,31 1,31 2024-03-26
Bollom Tsehaye 1,21 1,21 2024-03-26
Johannes Otterström 1,00 1,00 2024-03-26
Søren Melsing Frederiksen 0,96 0,96 2023-02-01
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2024-05-10 Årsstämma 2023

  • 2024-05-30 Delårsrapport 2024-Q1

  • 2024-07-12 Delårsrapport 2024-Q2

  • 2024-10-15 Delårsrapport 2024-Q3